MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-KL-02-0016214
M.P.C. Pharma Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹455.3 Cr
▲ 16% YoY
Net loss · FY 2024
₹1.97 Cr
Net margin -0.4%
EBITDA · FY 2024
₹4.68 Cr
EBITDA margin 1%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹3.76 Lakh
Issued & subscribed
Open charges
₹49.87 Cr
Satisfied ₹6.94 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
36
Provident fund records
About M.P.C. Pharma Private Limited
Data last updated:
M.P.C. Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 January 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51102TN2011PTC078857. Its GSTIN is 33AAGCM9678R1ZE (Tamil Nadu). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.76 Lakh. It is led by directors Rahul Mamman Abraham and Mamman Abraham.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ground Floor Portion C New No.38 Old No.167 Rangarajapuram Main Road Kodambakkam, Chennai, Tamil Nadu, India – 600024.
As per the financials filed for FY 2024, the company reported a revenue of ₹455.3 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹1.97 Cr (net margin -0.4%) and EBITDA of ₹4.68 Cr (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 85% over five years.
The company has about 36 employees on its provident fund (EPFO) records. Its group structure includes 8 subsidiaries.
The company is associated with 1 brand: MPC Pharma. As per MCA filings, the company has open charges of ₹49.87 Cr and satisfied charges of ₹6.94 Cr on record. The company has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in May 2020. Its 3 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger; the largest is Royal Canin India Private Limited with revenue of ₹473.84 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2022, listing 39 overdue payments to 5 micro and small suppliers.
M.P.C. Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0016214). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mpcpharma.com.
Company details
CIN U51102TN2011PTC078857
Registration Number 078857
Incorporation Date 17 January 2011
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KL-02-0016214
Recognitions & Rankings of M.P.C. Pharma
Contact details
M.P.C. Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its website is mpcpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGround Floor Portion C New No.38 Old No.167 Rangarajapuram Main Road Kodambakkam, Chennai, Tamil Nadu, India – 600024
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of M.P.C. Pharma Private Limited, buy the company report.
Comprehensive company report
M.P.C. Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
M.P.C. Pharma operates one associated brand: MPC Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distributes a diverse range of pharmaceutical drugs to healthcare providers. | mpcpharma.in |
Business activity
The main business activity of M.P.C. Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of M.P.C. Pharma Private Limited, buy the company report.
Financials of M.P.C. Pharma Private Limited
FY 2024 filings availableM.P.C. Pharma Private Limited reported revenue of ₹455.3 Cr (up 16% YoY) for FY 2024.
Revenue · FY 2024
₹455.3 Cr ▲ 16%
Net loss · FY 2024
₹1.97 Cr margin -0.4%
EBITDA · FY 2024
₹4.68 Cr margin 1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 17%
5 years · compounded
▲ 85%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 13%
5 years · compounded
▲ 70%
Revenue has grown at a compounded annual rate (CAGR) of 85% over five years, including 16% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.97 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of M.P.C. Pharma Private Limited, buy the company report.
Board of directors of M.P.C. Pharma Private Limited
M.P.C. Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Mamman Abraham Also directs: Senlora International Gold LLP, Newmalayalam Steel Limited, Cure Genic Hygiene Private Limited and 5 more | Director | 17 Jan 2011 | 15 Years 9 Months | Current |
| Mamman Abraham Also directs: Greenspecialities Private Limited, Medigenmed Care Private Limited, VS Enterprises Private Limited and 3 more | Director | 17 Jan 2011 | 15 Years 9 Months | Current |
Peer comparison
M.P.C. Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Royal Canin India Private Limited | ₹473.84 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Aadishwar Excipients Private Limited | ₹472.49 Cr (FY 2025) | 42.0% | Chennai, Tamil Nadu, India | |||
| Dhruvi Pharma Private Limited | ₹471.76 Cr (FY 2023) | 22.0% | Hyderabad, Telangana, India | |||
| M.P.C. Pharma Private Limitedthis company | ₹455.3 Cr (FY 2024) | -₹1.97 Cr | -0.4% | 16.0% | 36 | Chennai, Tamil Nadu, India |
To see the full peer comparison of M.P.C. Pharma Private Limited, buy the company report.
Auditor
M.P.C. Pharma Private Limited is audited by RAJIV AND RAJAGOPAL for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJIV AND RAJAGOPAL | FY 2023 | 006491S |
Shareholding
The shareholding of M.P.C. Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of M.P.C. Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹49.87 Cr
Satisfied charges
₹6.94 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 May 2025 | 101096149 | Others | ₹2 Cr | Open | |
| 05 Mar 2025 | 101073646 | Others | ₹7.6 Lakh | Open | |
| 05 Mar 2025 | 101073668 | Others | ₹3.81 Lakh | Open | |
| 05 Mar 2025 | 101073679 | Others | ₹15.75 Lakh | Open | |
| 04 Feb 2025 | 101055664 | Others | ₹3.35 Lakh | Open |
To see the full charge records of M.P.C. Pharma Private Limited, buy the company report.
Total charge records: 27 View all charges
Deals & funding
M.P.C. Pharma Private Limited has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in May 2020.
Total deals
4
Rights issues
2
Secondary share transfers
2
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2020 | Rights issue | ₹12.86 Cr | Investors: 4 individuals |
| May 2019 | Rights issue | ₹9.16 Cr | Investors: 4 individuals |
| Aug 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving M.P.C. Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
M.P.C. Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2022, listing 39 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Uni Drugs | |||
| an individual supplier | |||
| Uni Pharma | |||
| Medi Combines | |||
| Falcon International Drug Company |
To see the full MSME payment records of M.P.C. Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
M.P.C. Pharma has 8 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
8
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Greenspecialities Private Limited | U24230KL2019PTC058138 | |
| Medigenmed Care Private Limited | U24230KL2019PTC058402 | |
| VS Enterprises Private Limited | U24299KL2019PTC057811 | |
| Haeal Enterprises Private Limited | U24299KL2020PTC066280 | |
| Anandha Pharmacy Private Limited | U24304KL2019PTC058579 | |
| Bio Pharma Cochin Private Limited | U36900KL2019PTC056737 |
To see the full group structure of M.P.C. Pharma Private Limited, buy the company report.
Employees & EPFO
M.P.C. Pharma Private Limited has a workforce of 36 employees on its EPFO records as of Apr 06, 2024, across 2 active EPFO establishments.
Employee count
36
Active EPFO establishments
2
Employee growth
-30.77%
GST
M.P.C. Pharma has 5 GST registrations: 4 active and 1 cancelled or inactive.
Total GSTINs
5
Active
4
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCM9678R1ZE | Tamil Nadu | Active | 01 Jul 2017 |
| 33AAGCM9678R2ZD | Tamil Nadu | Active | 19 Nov 2019 |
| 32AAGCM9678R1ZG | Kerala | Active | 01 Jul 2017 |
| 27AAGCM9678R1Z7 | Maharashtra | Active | 03 Dec 2018 |
To see the full GST registrations and return filing status of M.P.C. Pharma Private Limited, buy the company report.
Recent activity
M.P.C. Pharma Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Pameela Mamman ceased to be Director on 27 Aug 2024.
Charges
A charge registered on 05 Aug 2025 via Charge ID 101148233 with Others was fully satisfied on 24 Nov 2025.
Charges
A charge with Others of Rs. 660.00 Lakh registered on 30 May 2023 with Charge ID 100728323 was modified on 24 Nov 2025.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 101148233 was registered on 05 Aug 2025.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 101096149 was registered on 05 May 2025.
Charges
A charge with Others amounted to Rs. 7.60 Lakh with Charge ID 101073646 was registered on 05 Mar 2025.
Charges
A charge with Others amounted to Rs. 3.81 Lakh with Charge ID 101073668 was registered on 05 Mar 2025.
Charges
A charge with Others amounted to Rs. 15.75 Lakh with Charge ID 101073679 was registered on 05 Mar 2025.
Charges
A charge registered on 29 Aug 2024 via Charge ID 100973343 with Others was fully satisfied on 28 Feb 2025.
Charges
A charge with Others amounted to Rs. 3.35 Lakh with Charge ID 101055664 was registered on 04 Feb 2025.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 101038508 was registered on 08 Jan 2025.
AGM
M.P.C. Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100973343 was registered on 29 Aug 2024.
30 earlier events are in the company report.
Frequently asked questions
M.P.C. Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 January 2011 (15+ years old) and is registered under CIN U51102TN2011PTC078857.
M.P.C. Pharma has 2 current directors:
- Rahul Mamman Abraham - Director
- Mamman Abraham - Director
The latest financial statements of M.P.C. Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of M.P.C. Pharma is 33AAGCM9678R1ZE, registered in Tamil Nadu. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 33AAGCM9678R2ZD (Tamil Nadu), 32AAGCM9678R1ZG (Kerala), 27AAGCM9678R1Z7 (Maharashtra).
The CIN (Corporate Identification Number) of M.P.C. Pharma is U51102TN2011PTC078857. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
M.P.C. Pharma was incorporated on 17 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.
M.P.C. Pharma has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in May 2020.
The peers of M.P.C. Pharma by revenue are Royal Canin India Private Limited, Aadishwar Excipients Private Limited, Dhruvi Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Pameela Mamman ceased to be Director on 27 Aug 2024. Miriam Verghese ceased to be Additional Director on 29 Sep 2022. Mamman Abraham was appointed as Director on 17 Jan 2011. M.P.C. Pharma has 4 board changes on record in total.
Yes, M.P.C. Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-KL-02-0016214).
M.P.C. Pharma has 1 MSME Form 1 return on record for the period ending Mar 2022, listing 39 overdue payments to 5 micro and small suppliers. The latest return was filed on 30 Apr 2022.
M.P.C. Pharma can be reached through the website mpcpharma.com. Its registered office is in Chennai, Tamil Nadu, India.